References
- Sharma A, Tiwari S, Deb MK, et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56(2):106054. doi:https://doi.org/10.1016/j.ijantimicag.2020.106054.
- Abrishami M, Tohidinezhad F, Daneshvar R, et al. Ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran. Ocul Immunol Inflamm. 2020;28(5):739–744. doi:https://doi.org/10.1080/09273948.2020.1773868.
- Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev. 2013;77(1):144–156. doi:https://doi.org/10.1128/MMBR.00058-12.
- Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. doi:https://doi.org/10.1080/09273948.2020.1738501.
- Marinho PM, Marcos AA, Romano AC, et al. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:https://doi.org/10.1016/S0140-6736(20)31014-X.
- Vavvas DG, Sarraf D, Sadda SR. et al. Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication. Eye (Lond). 2020;9:1–2. doi:https://doi.org/10.1038/s41433-020-1084-9.
- Invernizzi A, Torre A, Parrulli S. et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi:https://doi.org/10.1016/j.eclinm.2020.100550.
- Choudhary R, Kapoor MS, Singh A, Bodakhe SH. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2016;29(1):7–16. doi:https://doi.org/10.1016/j.joco.2016.09.009.
- Lavi E, Type CL. I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp Mol Pathol. 2020;115:104474. doi:https://doi.org/10.1016/j.yexmp.2020.104474.
- Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopses of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28(5):721–725. doi:https://doi.org/10.1080/09273948.2020.1770301.
- Bettach E, Zadok D, Weill Y, et al. Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection. J Med Virol. 2020;93:139–140. In Press. doi:https://doi.org/10.1002/jmv.26229.
- Pereira LA, Soares LCM, Nascimento PA, et al. Retinal findings in hospitalised patients with severe COVID-19. Br J Ophthalmol. In Press, 2020:bjophthalmol-2020-317576. doi:https://doi.org/10.1136/bjophthalmol-2020-317576.
- Tang Y, Liu J, Zhang D. et al. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020;11:1708. doi:https://doi.org/10.3389/fimmu.2020.01708.
- Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond). 2020;3:1–2. doi:https://doi.org/10.1038/s41433-020-1069-8.
- Zago Filho LA, Lima LH, Melo GB. et al. Vitritis and outer retinal abnormalities in a patient with COVID-19. Ocul Immunol Inflamm. 2020;6:1–3. doi:https://doi.org/10.1080/09273948.2020.1821898.
- Pérez-Bartolomé F, Sánchez-Quirós J. Ocular manifestations of SARS-CoV-2: literature review. Arch Soc Esp Oftalmol. 2020;S0365-6691(20):30316. doi:https://doi.org/10.1016/j.oftal.2020.07.020.
- Singh S, Farr D, Kumar A. Ocular manifestations of emerging Flaviviruses and the blood-retinal barrier. Viruses. 2018;10(10):530. doi:https://doi.org/10.3390/v10100530.
- Cruz-Villegas V, Berrocal AM, Davis JL. Bilateral choroidal effusions associated with dengue fever. Retina. 2003;23(4):576–578. doi:https://doi.org/10.1097/00006982-200308000-00031.
- Akanda M, Gangaputra S, Kodati S, et al. Multimodalimaging in dengue-fever-associated maculopathy. Ocul Immunol Inflamm. 2018;26(5):671–676. doi:https://doi.org/10.1080/09273948.2017.1351571.